Drug selection of MDR1-transduced hematopoietic cells ex vivo increases transgene expression and chemoresistance in reconstituted bone marrow in mice

Gene Therapy

Volumn 7, Issue 4, 2000, Pages 348-358

  Licht, T ^a   Goldenberg, S K ^b   Vieira, W D ^b   Gottesman, M M ^b   Pastan, I ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Bone marrow transplantation; Chemotherapy; Gene therapy; Multidrug resistance; Selectable marker genes

Indexed keywords

COLCHICINE; DAUNORUBICIN; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; CONTROLLED STUDY; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSDUCTION; HEMATOPOIETIC CELL; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; TISSUE CULTURE; TRANSGENE;

ANIMALIA; MURINAE;

EID: 0034001743     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301087     Document Type: Article

References (52)

1. Klimecki WT, Futscher BW, Grogan TM, Dalton WS. P-glycoprotein expression and function in circulating blood cells from normal volunteers. Blood 1994; 83: 2451-2458.
2. Drach D et al. Subpopulations of normal and peripheral blood and bone marrow cells express a functional multidrug resistant phenotype. Blood 1992; 80: 2735-2739.
3. Chaudhary PM, Roninson IB. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 1991; 66: 85-94.
4. Chaudhary PM, Mechetner EB, Roninson IB. Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood 1992; 80: 2729-2734.
5. Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993; 62: 385-427.
6. Goldstein L et al. Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 1989; 81: 116-124.
7. Pirker R et al. MDR1 RNA expression is an independent prognostis factor in acute myeloid leukemia. Blood 1992; 80: 557-559.
8. Baldini N et al. Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome. New Engl J Med 1995; 333: 1380-1385.
9. Gottesman MM, Pastan I. The multidrug resistance (MDR1) gene as a selectable marker in gene therapy. In: Cohen-Haguenauer O, Boiron M (eds). Human Gene Transfer, vol. 219. Coloque INSERM/John Libbey Eurotext: London, 1991, pp 185-191.
10. Banerjee D et al. Gene therapy utilizing drug resistance genes: a review. Stem Cells 1994; 12: 378-385.
11. Licht T, Pastan I, Gottesman MM, Herrmann F. The multidrug resistance gene in gene therapy of cancer and hematopoietic disorders. Ann Hematol 1996; 72: 184-193.
12. Hanania EG et al. Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy. Proc Natl Acad Sci USA 1996; 93: 15346-15351.
13. Hesdorffer C et al. Phase 1 trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation. J Clin Oncol 1998; 16: 165-172.
14. Cowan K et al. Paclitaxel chemotherapy after autologous stum cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary (MDR1) in metastatic breast cancer patients. Clin Cancer Res 1999; 5: 1619-1628.
15. Moscow JA et al. Engraftment of MDR1 and NeoR gene-transduced hematopoietic cells after breast cancer chemotherapy. Blood 1999; 94: 52-61.
16. Galski H et al. Expression of a human multidrug resistance cDNA (MDR1) in the bone marrow of transgenic mice: resistance to daunomycin induced leukopenia. Mol Cell Biol 1989; 9: 4357-4363.
17. Mickisch GH et al. Chemotherapy and chemosensitization of transgenic mice which express the human multidrug resistance gene in bone marrow: efficacy, potency and toxicity. Cancer Res 1991; 51: 5417-5424.
18. Podda S et al. Transfer and expression of the human multiple drug resistance gene into live mice. Proc Natl Acad Sci USA 1992; 89: 9676-9680.
19. Sorrentino BP et al. Selection of drug-resistant bone marrow cells in vivo after retro viral transfer of human MDR1. Science 1992; 257: 99-103.
20. Bodine DM et al. Efficient retrovirus transduction of mouse pluripotent hematopoietic stem cells mobilized into the peripheral blood by treatment with granulocyte colony-stimulating factor and stem cell factor. Blood 1994; 84: 1482-1491.
21. Hanania EG, Deisseroth AB. Serial transplantation shows that early hematopoietic precursor cells arc transduced by MDR-1 retroviral vector in a mouse gene therapy model. Cancer Gene Ther 1994; 1: 21-25.
22. Licht T, Aksentijevich I, Gottesman MM, Pastan I. Efficient expression of functional human MDR1 gene in murine bone marrow after retroviral transduction of purified hematopoietic stem cells. Blood 1995; 86: 111-121.
23. + cells. Blood 1994; 84: 1408-1414.
24. Bertolini F et al. Retrovirus-mediated transfer of the multidrug resistance gene into human haematopoietic progenitor cells. Br J Haematol 1994; 88: 318-324.
25. Fruehauf S et al. Frequency analysis of multidrug resistance-1 gene transfer into human primitive hematopoietic progenitor cells using the cobblestone area-forming cell assay and detection of vector-mediated P-glycoprotein expression by rhodamine-123. Hum Gene Ther 1996; 7: 1219-1231.
26. Gottesman MM et al. Genetic analysis of the multidrug transporter. Annu Rev Genet 1995; 29: 607-649.
27. Aran JM, Gottesman MM, Pastan I. Drug-selected coexpression of human glucocerebrosidase and P-glycoprotein using a bicistronic vector. Proc Natl Acad Sci USA 1994; 91: 3176-3180.
28. Sugimoto Y et al. Retroviral co-expression of a multidrug-resistance gene (MDR1) and human alpha-galactosidase A for gene therapy of Fabry disease. Hum Gene Ther 1995; 6: 905-915.
29. Germann UA, Chin K-V, Pastan I, Gottesmann MM. Retroviral transfer of a chimeric multidrug resistance-adenosine deaminase gene. FASEB J 1990; 4: 1501-1507.
30. Sokolic RA et al. A bicistronic retrovirus vector containing a picornavirus internal ribosome entry site allows for correction of X-linked CGD by selection for MDR1 expression. Blood 1996; 87: 42-50.
31. Aran JM, Licht T, Gottesman MM, Pastan I. Complete restoration of glucocerebrosidase deficiency in Gaucher fibroblasts using a bicistronic MDR retrovirus and a new selection strategy. Hum Gene Ther 1996; 7: 2165-2175.
32. Blau CA, Neff T, Papayannopoulou T. Cytokine prestimulation as a gene therapy strategy: implications for using the MDR1 gene as a dominant selectable marker. Blood 1997; 89: 146-154.
33. Licht T et al. Retroviral transfer of human MDR1 gene to hematopoietic cells: effects of drug selection and of transcript splicing on expression of encoded P-glycoprotein. Hum Gene Ther 1999; 10: 2173-2185.
34. Zijlmans JM et al. The early phase of engraftment after murine blood cell transplantation is mediated by hematopoietic stem cells. Proc Natl Acad Sri USA 1998; 95: 725-729.
35. lo Lin-Sca-1+ hematopoietic stem cells. Blood 1994; 83: 3758-3779.
36. Capel B et al. Clonal contributions of small numbers of retrovirally marked hematopoietic stem cells engrafted in unirradiated neonatal mice. Proc Natl Acad Sci USA 1989; 86: 4564-4568.
37. Snodgrass R, Keller G. Clonal fluctuation within the hematopoietic system of mice reconstituted with retrovirus-infected cells. EMBO J 1987; 6: 3955-3960.
38. Bunting KD et al. Transduction of murine bone marrow cells with an MDR1 vector enables ex vivo cell expansion, but these expanded grafts cause a myeloproliferative syndrome in transplanted mice. Blood 1998; 92: 2269-2279.
39. Yonemura Y et al. Interleukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoietic stem cells. Proc Natl Acad Sci USA 1996; 93: 4040-4044.
40. Peters SO, Kittler EL, Ramshaw HS, Quesenberry PJ. Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood 1996; 87: 30-37.
41. + progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), 1L-6, IL-3, interferon-gamma, and erythropoietin. Blood 1993; 81: 2579-2584.
42. Sorrentino BP, McDonagh KT, Woods D, Orlic D. Expression of retroviral vectors containing the human multidrug resistance 1 cDNA in hematopoietic cells of transplanted mice. Blood 1995; 86: 491-501.
43. McLachlin JR et al. Expression of a human complementary DNA for the human multidrug resistance gene in murine hematopoietic precursor cells with the use of retroviral gene transfer. J Natl Cancer Inst 1990; 82: 1260-1263.
44. Eckert HG et al. High-dose multidrug resistance in primary human hematopoietic progenitor cells transduced with optimized retroviral vectors. Blood 1996; 88: 3407-3415.
45. Safa AR et al. Molecular basis of preferential resistance to colchicine in multidrug-resistant human cells conferred by Gly-185-Val-185 substitution in P-glycoprotein. Proc Natl Acad Sci USA 1990; 87: 7225-7229.
46. Cardarelli CO, Aksentijevich I, Pastan I, Gottesman MM. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters. Cancer Res 1995; 55: 1086-1091.
47. Richardson C, Bank A. Preselection of transduced murine hematopoietic stem cell populations leads to increased long-term stability and expression of the human multiple drug resistance gene. Blood 1995; 86: 2579-2589.
48. 6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res 1997; 57: 5093-5099.
49. Flasshove M et al. Ex vivo expansion and selection of human CD34-positive peripheral blood progenitor cells after introduction of a mutated dihydrofolate reductase cDNA via retroviral gene transfer. Blood 1995; 85: 556-574.
50. Zhao SC, Banerjee D, Mineishi S, Bertino JR. Post-transplant methotrexate administration leads to improved curability of mice bearing a mammary tumor transplanted with marrow transduced with a mutant human dihydrofolate reductase cDNA. Hum Gene Ther 1997; 8: 903-909.
51. Allay JA et al. In vivo selection of retrovirally transduced hematopoietic stem cells. Nature Med 1998; 4: 1136-1143.
52. Pastan I et al. A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. Proc Natl Acad Sci USA 1988; 85: 4486-4490.